ESR1 and breast carcinoma: For example, activation of the estrogen receptor inhibits miR-148a levels in breast cancer cells and COX-2 induces miR-526b expression through the prostaglandin receptor, which promotes breast cancer progression (Majumder et al., 2015; Tao et al., 2015).